Valuation: Enovis Corporation

Market Cap 1.68B 1.46B 1.36B 1.25B 2.35B 160B 2.39B 16B 6.28B 79.74B 6.3B 6.16B 267B P/E 2026 *
243x
P/E 2027 * 30.3x
Enterprise Value 2.88B 2.51B 2.33B 2.14B 4.05B 275B 4.11B 27.51B 10.8B 137B 10.83B 10.6B 460B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.11x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day-0.51%
1 week+7.84%
1 month+40.82%
3 months+24.36%
6 months+32.26%
Current year+9.42%
1 week 27.46
Extreme 27.465
30.52
1 month 20.23
Extreme 20.23
30.52
Current year 19.14
Extreme 19.14
30.52
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Free

Director

846 0.0015%
31/3/26 Free

Director

770 0.0013%
7/3/26 Free

Chief Executive Officer

143,923 0.2518%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+7.84%+8.77%-54.38% 1.68B
-6.42%-1.38%-17.07%+14.92% 125B
-2.48%+1.62%-0.34%-2.24% 13.12B
-1.07%+8.56%+93.66%+116.13% 9.83B
+1.11%+10.55%-41.05%-67.95% 4.86B
-2.28%-0.67%-2.39%+35.25% 2.61B
+0.60%+5.00%-15.24%-21.40% 1.67B
+1.24%+5.88%-22.03%-30.49% 1.68B
+0.38%+2.07%-59.68%-82.55% 1.45B
Average -1.05%+2.94%-6.15%-10.30% 17.97B
Weighted average by Cap. -5.21%-0.16%-9.61%+15.08%

Financials

2026 *2027 *
Net sales 2.34B 2.04B 1.9B 1.74B 3.29B 224B 3.34B 22.36B 8.78B 111B 8.81B 8.61B 374B 2.47B 2.14B 2B 1.83B 3.46B 235B 3.51B 23.52B 9.23B 117B 9.26B 9.06B 393B
Net income 2.98M 2.59M 2.41M 2.21M 4.18M 284M 4.25M 28.42M 11.15M 142M 11.19M 10.95M 475M 54.14M 47.06M 43.81M 40.22M 75.95M 5.17B 77.13M 516M 203M 2.57B 203M 199M 8.63B
Net Debt 1.21B 1.05B 977M 897M 1.69B 115B 1.72B 11.51B 4.52B 57.36B 4.53B 4.43B 192B 1.07B 929M 864M 794M 1.5B 102B 1.52B 10.19B 4B 50.77B 4.01B 3.92B 170B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
31/07/26 US$29.15 -0.51% 770,280
30/07/26 US$29.30 -3.17% 869,470
29/07/26 US$30.26 +2.51% 1,083,115
28/07/26 US$29.52 +4.50% 1,301,951
27/07/26 US$28.25 +4.51% 827,686
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
29.15USD
Average target price
41.58USD
Spread / Average Target
+42.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock